The latest Google Mobility Report published on 23 February paints an encouraging picture of store footfall and visits to recreational facilities around the world, especially in Europe.
Belgium and Spain have recorded positive mobility trends after a period of stagnation since mid-January, the moving average improved, reaching 36% and 43% compared to baseline*. Italy eased its pandemic restrictions across most regions on 1 February, allowing restaurants and bars to reopen until 6 pm. As a result, the increase in mobility seen since the end of January has gained further steam, the moving average slightly improved, reaching 31% compared to baseline. Mobility trends have risen in France and Germany after a decline at the beginning of the month, the moving average increased and reached 41% and 53% compared to baseline. In the United Kingdom, mobility still lags behind mainland Europe, despite an upward trend since mid-January.
In the United States and Japan, mobility trends rebounded slightly after a brief dip, but levels in these two countries remain above those in mainland Europe.
In addition, vaccination campaigns have made good progress across the world. According to the latest data published on the University of Oxford’s “Our World in Data” website, 102.74 million doses of Covid-19 vaccines had been administered in the eight countries referred to above, accounting for over 45% of the doses administered worldwide. Based on the number of vaccines given relative to population size, the United Kingdom, the world’s first country to have authorised the vaccine (2 December), leads the way with 27.86 doses administered per 100 citizens**, or a total of 18.91 million doses. Next comes the United States, with 19.87 doses per 100 citizens, or a total of 66.46 million doses. Spain’s vaccination ratio stands at 7.03%, followed by Germany, Italy, Belgium and France with ratios of 6.62%, 6.33%, 6.12% and 6.09% respectively, or a total of 17.34 million doses in these five Eurozone countries. Japan is at the rear with a very low level of 0.01%.
** Number of people having received at least one dose